Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Radiopharmaceutical Market Report for Period 2017 till 2022

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Scope of the Report:
This report focuses on the Radiopharmaceutical in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Bayer
Triad Isotopes
Lantheus
GE Healthcare
Mallinckrodt
Eli Lilly
Bracco Imaging
SIEMENS
Navidea
Nordion
IBA Group
Jubilant Pharma

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
SPECT Radioisotopes
PET Radioisotopes
Other Diagnostic Radioisotopes
Therapeutic Radioisotopes

Market Segment by Applications, can be divided into
Oncology
Cardiology
Other

There are 15 Chapters to deeply display the global Radiopharmaceutical market.

Chapter 1, to describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Radiopharmaceutical Introduction
1.2 Market Analysis by Type
1.2.1 SPECT Radioisotopes
1.2.2 PET Radioisotopes
1.2.3 Other Diagnostic Radioisotopes
1.2.4 Therapeutic Radioisotopes
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Radiopharmaceutical Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Bayer Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Triad Isotopes
2.2.1 Business Overview
2.2.2 Radiopharmaceutical Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Lantheus
2.3.1 Business Overview
2.3.2 Radiopharmaceutical Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Lantheus Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GE Healthcare
2.4.1 Business Overview
2.4.2 Radiopharmaceutical Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mallinckrodt
2.5.1 Business Overview
2.5.2 Radiopharmaceutical Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Radiopharmaceutical Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bracco Imaging
2.7.1 Business Overview
2.7.2 Radiopharmaceutical Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 SIEMENS
2.8.1 Business Overview
2.8.2 Radiopharmaceutical Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Navidea
2.9.1 Business Overview
2.9.2 Radiopharmaceutical Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Navidea Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Nordion
2.10.1 Business Overview
2.10.2 Radiopharmaceutical Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Nordion Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 IBA Group
2.11.1 Business Overview
2.11.2 Radiopharmaceutical Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 IBA Group Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Jubilant Pharma
2.12.1 Business Overview
2.12.2 Radiopharmaceutical Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Radiopharmaceutical Market Competition, by Manufacturer
3.1 Global Radiopharmaceutical Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Radiopharmaceutical Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Radiopharmaceutical Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Radiopharmaceutical Manufacturer Market Share
3.4.2 Top 5 Radiopharmaceutical Manufacturer Market Share
3.5 Market Competition Trend
4 Global Radiopharmaceutical Market Analysis by Regions
4.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceutical Sales by Regions (2012-2017)
4.1.2 Global Radiopharmaceutical Revenue by Regions (2012-2017)
4.2 North America Radiopharmaceutical Sales and Growth (2012-2017)
4.3 Europe Radiopharmaceutical Sales and Growth (2012-2017)
4.4 Asia-Pacific Radiopharmaceutical Sales and Growth (2012-2017)
4.5 South America Radiopharmaceutical Sales and Growth (2012-2017)
4.6 Middle East and Africa Radiopharmaceutical Sales and Growth (2012-2017)
5 North America Radiopharmaceutical by Countries, Type, Application and Manufacturers
5.1 North America Radiopharmaceutical Sales, Revenue and Market Share by Countries
5.1.1 North America Radiopharmaceutical Sales by Countries (2012-2017)
5.1.2 North America Radiopharmaceutical Revenue by Countries (2012-2017)
5.1.3 USA Radiopharmaceutical Sales and Growth (2012-2017)
5.1.4 Canada Radiopharmaceutical Sales and Growth (2012-2017)
5.1.5 Mexico Radiopharmaceutical Sales and Growth (2012-2017)
5.2 North America Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 North America Radiopharmaceutical Sales by Manufacturers (2016-2017)
5.2.2 North America Radiopharmaceutical Revenue by Manufacturers (2016-2017)
5.3 North America Radiopharmaceutical Sales by Type (2012-2017)
5.4 North America Radiopharmaceutical Sales by Application (2012-2017)
6 Europe Radiopharmaceutical by Countries, Type, Application and Manufacturers
6.1 Europe Radiopharmaceutical Sales, Revenue and Market Share by Countries
6.1.1 Europe Radiopharmaceutical Sales by Countries (2012-2017)
6.1.2 Europe Radiopharmaceutical Revenue by Countries (2012-2017)
6.1.3 Germany Radiopharmaceutical Sales and Growth (2012-2017)
6.1.4 UK Radiopharmaceutical Sales and Growth (2012-2017)
6.1.5 France Radiopharmaceutical Sales and Growth (2012-2017)
6.1.6 Russia Radiopharmaceutical Sales and Growth (2012-2017)
6.1.7 Italy Radiopharmaceutical Sales and Growth (2012-2017)
6.2 Europe Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Europe Radiopharmaceutical Sales by Manufacturers (2016-2017)
6.2.2 Europe Radiopharmaceutical Revenue by Manufacturers (2016-2017)
6.3 Europe Radiopharmaceutical Sales by Type (2012-2017)
6.4 Europe Radiopharmaceutical Sales by Application (2012-2017)
7 Asia-Pacific Radiopharmaceutical by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Radiopharmaceutical Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Radiopharmaceutical Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Radiopharmaceutical Revenue by Countries (2012-2017)
7.1.3 China Radiopharmaceutical Sales and Growth (2012-2017)
7.1.4 Japan Radiopharmaceutical Sales and Growth (2012-2017)
7.1.5 Korea Radiopharmaceutical Sales and Growth (2012-2017)
7.1.6 India Radiopharmaceutical Sales and Growth (2012-2017)
7.1.7 Southeast Asia Radiopharmaceutical Sales and Growth (2012-2017)
7.2 Asia-Pacific Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Radiopharmaceutical Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Radiopharmaceutical Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Radiopharmaceutical Sales by Type (2012-2017)
7.4 Asia-Pacific Radiopharmaceutical Sales by Application (2012-2017)
8 South America Radiopharmaceutical by Countries, Type, Application and Manufacturers
8.1 South America Radiopharmaceutical Sales, Revenue and Market Share by Countries
8.1.1 South America Radiopharmaceutical Sales by Countries (2012-2017)
8.1.2 South America Radiopharmaceutical Revenue by Countries (2012-2017)
8.1.3 Brazil Radiopharmaceutical Sales and Growth (2012-2017)
8.1.4 Argentina Radiopharmaceutical Sales and Growth (2012-2017)
8.1.5 Columbia Radiopharmaceutical Sales and Growth (2012-2017)
8.2 South America Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
8.2.1 South America Radiopharmaceutical Sales by Manufacturers (2016-2017)
8.2.2 South America Radiopharmaceutical Revenue by Manufacturers (2016-2017)
8.3 South America Radiopharmaceutical Sales by Type (2012-2017)
8.4 South America Radiopharmaceutical Sales by Application (2012-2017)
9 Middle East and Africa Radiopharmaceutical by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Radiopharmaceutical Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Radiopharmaceutical Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Radiopharmaceutical Revenue by Countries (2012-2017)
9.1.3 Saudi Arabia Radiopharmaceutical Sales and Growth (2012-2017)
9.1.4 UAE Radiopharmaceutical Sales and Growth (2012-2017)
9.1.5 Egypt Radiopharmaceutical Sales and Growth (2012-2017)
9.1.6 Nigeria Radiopharmaceutical Sales and Growth (2012-2017)
9.1.7 South Africa Radiopharmaceutical Sales and Growth (2012-2017)
9.2 Middle East and Africa Radiopharmaceutical Sales and Revenue (value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Radiopharmaceutical Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Radiopharmaceutical Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Radiopharmaceutical Sales by Type (2012-2017)
9.4 Middle East and Africa Radiopharmaceutical Sales by Application (2012-2017)
10 Global Radiopharmaceutical Market Segment by Type
10.1 Global Radiopharmaceutical Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Radiopharmaceutical Sales and Market Share by Type (2012-2017)
10.1.2 Global Radiopharmaceutical Revenue and Market Share by Type (2012-2017)
10.2 SPECT Radioisotopes Sales Growth and Price
10.2.1 Global SPECT Radioisotopes Sales Growth (2012-2017)
10.2.2 Global SPECT Radioisotopes Price (2012-2017)
10.3 PET Radioisotopes Sales Growth and Price
10.3.1 Global PET Radioisotopes Sales Growth (2012-2017)
10.3.2 Global PET Radioisotopes Price (2012-2017)
10.4 Other Diagnostic Radioisotopes Sales Growth and Price
10.4.1 Global Other Diagnostic Radioisotopes Sales Growth (2012-2017)
10.4.2 Global Other Diagnostic Radioisotopes Price (2012-2017)
10.5 Therapeutic Radioisotopes Sales Growth and Price
10.5.1 Global Therapeutic Radioisotopes Sales Growth (2012-2017)
10.5.2 Global Therapeutic Radioisotopes Price (2012-2017)
11 Global Radiopharmaceutical Market Segment by Application
11.1 Global Radiopharmaceutical Sales Market Share by Application (2012-2017)
11.2 Oncology Sales Growth (2012-2017)
11.3 Cardiology Sales Growth (2012-2017)
11.4 Other Sales Growth (2012-2017)
12 Radiopharmaceutical Market Forecast (2017-2022)
12.1 Global Radiopharmaceutical Sales, Revenue and Growth Rate (2017-2022)
12.2 Radiopharmaceutical Market Forecast by Regions (2017-2022)
12.2.1 North America Radiopharmaceutical Market Forecast (2017-2022)
12.2.2 Europe Radiopharmaceutical Market Forecast (2017-2022)
12.2.3 Asia-Pacific Radiopharmaceutical Market Forecast (2017-2022)
12.2.4 South America Radiopharmaceutical Market Forecast (2017-2022)
12.2.5 Middle East and Africa Radiopharmaceutical Market Forecast (2017-2022)
12.3 Radiopharmaceutical Market Forecast by Type (2017-2022)
12.4 Radiopharmaceutical Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 34884

Category: 11

Published date: 2017-10-25 15:54:41

Number of Pages: 124

Publisher Name: GIR

Over all Rating: 86 % (Average of Ratings provided by clients)